Skip to content

Observational study For Investigating the ability of Recuperation of work/ house work State with adalimumab treatment in RA patients in tohoku

Observational study For Investigating the ability of Recuperation of work/ house work State with adalimumab treatment in RA patients in tohoku - AT HOME study

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000017429
Enrollment
100
Registered
2015-05-07
Start date
2015-04-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

None listed

Sponsors

Tohoku uviversity hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Age => 20 years and 75<years at registration (2)Diagnosis of rheumatoid arthritis according to the American College of Rheumatology ACR criteria (3) Patients who want to be treated with adalimumab and MTX (4)Consent to study participation has been obtained in writing from the patient personally

Exclusion criteria

Exclusion criteria: (1)Patients who pregnant (2)Patients who cannot use the drug in this study by contraindication. (3)The principal investigator or co-investigator has determined that the participation of the patient in the study would not be appropriate

Design outcomes

Primary

MeasureTime frame
Change in percent overall work impairment (at the last observation, up to week72) in paid workers, by the Work Productivity and Activity Impairment Questionnaire (WPAI)

Countries

Japan

Contacts

Public ContactTomonori ISHII

Tohoku university hospital Crieto

tishii@med.tohoku.ac.jp022-717-7165

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026